| 1 |
Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34:641-7.
DOI
ScienceOn
|
| 2 |
Lisboa T, Blot S, Waterer GW, Canalis E, de Mendoza D, Rodriguez A, et al. Radiologic progression of pulmonary infiltrates predicts a worse prognosis in severe community-acquired pneumonia than bacteremia. Chest 2009;135:165-72.
DOI
ScienceOn
|
| 3 |
Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009;150:19-26.
DOI
ScienceOn
|
| 4 |
Obaro SK, Monteil MA, Henderson DC. The pneumococcal problem. BMJ 1996;312:1521-5.
DOI
ScienceOn
|
| 5 |
Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009;180:48-58.
DOI
ScienceOn
|
| 6 |
Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994;154:2666-77.
DOI
ScienceOn
|
| 7 |
Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;1:CD000422.
|
| 8 |
Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366:1165-74.
DOI
ScienceOn
|
| 9 |
Deng JC, Standiford TJ. The systemic response to lung infection. Clin Chest Med 2005;26:1-9.
DOI
ScienceOn
|
| 10 |
Christ-Crain M, Morgenthaler NG, Stolz D, Muller C, Bingisser R, Harbarth S, et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care 2006;10:R96.
DOI
|
| 11 |
Niederman MS. Recent advances in community-acquired pneumonia: inpatient and outpatient. Chest 2007;131:1205-15.
DOI
ScienceOn
|
| 12 |
Lin MC, Chen YC, Wu JT, Ko YC, Wang CC. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest 2009;136:205- 11.
DOI
ScienceOn
|
| 13 |
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89.
DOI
ScienceOn
|
| 14 |
Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007;176:162-6.
DOI
ScienceOn
|
| 15 |
Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320:1297-303.
DOI
ScienceOn
|
| 16 |
Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999;353:1819-23.
DOI
ScienceOn
|
| 17 |
Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, HuberPR, Tamm M, et al. Effect of procalcitonin- guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-7.
DOI
ScienceOn
|
| 18 |
Ewig S, Kleinfeld T, Bauer T, Seifert K, Schafer H, Goke N. Comparative validation of prognostic rules for community- acquired pneumonia in an elderly population. Eur Respir J 1999;14:370-5.
|
| 19 |
Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
DOI
ScienceOn
|
| 20 |
Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006;27:151-7.
DOI
ScienceOn
|
| 21 |
Menendez R, Torres A, Zalacain R, Aspa J, Martin-Villasclaras JJ, Borderias L, et al. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 2005;172:757-62.
DOI
ScienceOn
|
| 22 |
Menendez R, Martinez R, Reyes S, Mensa J, Filella X, Marcos MA, et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009;64:587-91.
DOI
ScienceOn
|
| 23 |
Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify lowrisk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
DOI
ScienceOn
|
| 24 |
Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993;270:1965-70.
DOI
ScienceOn
|
| 25 |
Song JH, Jung KS, Kang MW, Kim DJ, Pai H, Suh GY, et al. Treatment guidelines for community-acquired pneumonia in Korea: an evidence-based approach to appropriate antimicrobial therapy. Tuberc Respir Dis 2009;67:281-302.
DOI
ScienceOn
|
| 26 |
Korea National Statistical Office. Annual report on the cause of death statistics 2007: nationwide. Daejeon: Korea National Statistical Office; 2007.
|
| 27 |
Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin- based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the Pro- HOSP randomized controlled trial. JAMA 2009;302: 1059-66.
DOI
ScienceOn
|
| 28 |
Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug- resistant Streptococcus pneumoniae in the United- States. N Engl J Med 2000;343:1917-24.
DOI
ScienceOn
|
| 29 |
Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008;47:735-43.
DOI
ScienceOn
|
| 30 |
Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989;139:877-84.
DOI
ScienceOn
|
| 31 |
Vincent JL. Nosocomial infections in adult intensivecare units. Lancet 2003;361:2068-77.
DOI
ScienceOn
|
| 32 |
Qadeer MA, Richter JE, Brotman DJ. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med 2006;1:13-20.
DOI
ScienceOn
|
| 33 |
Nardino RJ, Vender RJ, Herbert PN. Overuse of acidsuppressive therapy in hospitalized patients. Am J Gastroenterol 2000;95:3118-22.
|
| 34 |
Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther 2003; 17:1503-6.
DOI
ScienceOn
|
| 35 |
Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital- acquired pneumonia. JAMA 2009;301:2120-8.
DOI
ScienceOn
|
| 36 |
Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children-- Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-2.
|
| 37 |
Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009;302:1896-902.
DOI
ScienceOn
|
| 38 |
Sin DD, Tashkin D, Zhang X, Radner F, Sjobring U, Thoren A, et al. Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. Lancet 2009;374:712-9.
DOI
ScienceOn
|
| 39 |
Ek A, Larsson K, Siljerud S, Palmberg L. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. Allergy 1999;54:691-9.
DOI
ScienceOn
|
| 40 |
Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361: 680-9.
DOI
ScienceOn
|
| 41 |
Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother 2006;40:1261-6.
DOI
ScienceOn
|
| 42 |
Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300:2407-16.
DOI
ScienceOn
|
| 43 |
Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med 2009;169:219-29.
DOI
ScienceOn
|
| 44 |
Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134-41.
DOI
ScienceOn
|
webmaster
